The U.S. Food & Drug Administration (FDA) issued a favorable response to a qualified health claim petition filed by Nutrition 21, recognizing chromium picolinate as a nutritional supplement that may reduce the risk of insulin resistance and possibly type 2 diabetes.

In a letter to the company, the FDA's Center for Food Safety & Applied Nutrition concluded that there is credible evidence to support the following qualified health claim: